Boston Partners
AMN icon

Boston Partners’s AMN Healthcare AMN Stock Holding History

Boston Partners’s Portfolio AMN Stock Details AMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.2M Sell
1,674,561
-463,827
-22% -$12M 0.05% 272
2026
Q1 		$39.2M Buy
2,138,388
+1,103,243
+107% +$21M 0.04% 283
2025
Q4 		$16.3M Buy
1,035,145
+1,021,672
+7,583% +$18.2M 0.02% 386
2025
Q3 		$261K Buy
13,473
+3,370
+33% +$65.8K ﹤0.01% 728
2025
Q2 		$209K Buy
10,103
+17
+0.2% +$353 ﹤0.01% 702
2025
Q1 		$247K Sell
10,086
-1,311,286
-99% -$33.7M ﹤0.01% 684
2024
Q4 		$31.6M Sell
1,321,372
-412,675
-24% -$13.1M 0.04% 281
2024
Q3 		$73.3M Sell
1,734,047
-85,204
-5% -$4.47M 0.09% 222
2024
Q2 		$93.1M Sell
1,819,251
-73,594
-4% -$4.17M 0.12% 211
2024
Q1 		$118M Sell
1,892,845
-991,705
-34% -$67.5M 0.14% 200
2023
Q4 		$216M Buy
2,884,550
+1,461,541
+103% +$105M 0.29% 131
2023
Q3 		$121M Buy
1,423,009
+307,183
+28% +$29.1M 0.17% 177
2023
Q2 		$121M Buy
1,115,826
+783,966
+236% +$74.3M 0.16% 184
2023
Q1 		$27.8M Buy
331,860
+99,268
+43% +$9.35M 0.04% 276
2022
Q4 		$23.8M Buy
232,592
+66,970
+40% +$7.71M 0.03% 284
2022
Q3 		$17.9M Buy
+165,622
New +$18.2M 0.03% 301
2017
Q4 		– Sell
-54,750
Closed -$2.5M – 745
2017
Q3 		$2.5M Sell
54,750
-12,400
-18% -$474K ﹤0.01% 636
2017
Q2 		$2.62M Sell
67,150
-59,450
-47% -$2.28M ﹤0.01% 618
2017
Q1 		$5.14M Sell
126,600
-14,350
-10% -$562K 0.01% 493
2016
Q4 		$5.42M Buy
140,950
+69,620
+98% +$2.38M 0.01% 488
2016
Q3 		$2.27M Buy
+71,330
New +$2.71M ﹤0.01% 644

Other funds holding AMN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Boston Partners's AMN Position: Q2 2026 in Review

Boston Partners reduced its AMN Healthcare (AMN) stake by 22% in Q2 2026, selling an estimated $12M and leaving 1,674,561 shares worth $54.2M. The position accounts for 0.05% of the portfolio, ranked #272.

Boston Partners first reported a position in AMN in Q3 2016 and has held it in 21 quarters since. The position peaked at $216M in Q4 2023. 285 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

  • Boston Partners held 1,674,561 shares of AMN Healthcare worth $54.2M as of Q2 2026.
  • Boston Partners sold 463,827 AMN Healthcare shares in Q2 2026, an estimated $12M.
  • AMN Healthcare made up 0.05% of Boston Partners's portfolio in Q2 2026, its #272 holding.
  • Boston Partners first reported a position in AMN Healthcare in Q3 2016 and has held it in 21 quarters since.
  • Boston Partners's AMN Healthcare position peaked at $216M in Q4 2023.
  • 285 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on Boston Partners's 13F filing for Q2 2026, filed 4 Aug 2026.